Literature DB >> 9190925

Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system.

S Poliak1, F Mor, P Conlon, T Wong, N Ling, J Rivier, W Vale, L Steinman.   

Abstract

Corticotropin-releasing factor (CRF) exerts a major role in the stress response. Both CRF and urocortin, a newly discovered neuropeptide homologous to CRF, suppressed experimental autoimmune encephalomyelitis (EAE). Suppression of paralysis with CRF involved stimulation of the hypothalamic-pituitary-adrenal axis and inhibitory effects on an encephalitogenic T cell line. While CRF increased glucocorticoid production, which is known to block EAE, it also suppressed EAE in adrenalectomized rats, where glucocorticoid stimulation via CRF plays no role. Moreover, the encephalitogenicity of a T cell line exposed to CRF in vitro was reduced. Stress may influence autoimmune disease through the hypothalamic-pituitary-adrenal axis and directly via the immune system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190925

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  The intricate interplay among body weight, stress, and the immune response to friend or foe.

Authors:  Lawrence Steinman; Paul Conlon; Rich Maki; Alan Foster
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response.

Authors:  Elena Gonzalez-Rey; Alejo Chorny; Nieves Varela; Gema Robledo; Mario Delgado
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 3.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

4.  Substance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition.

Authors:  Priscila O Barros; Thais B Ferreira; Morgana M M Vieira; Carla Renata M Almeida; Carlos Fernando Araújo-Lima; Renato G Silva-Filho; Joana Hygino; Regis M Andrade; Arnaldo F Andrade; Cleonice A Bento
Journal:  J Clin Immunol       Date:  2010-09-24       Impact factor: 8.317

5.  Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression.

Authors:  Maria P Lemos; Kyu Y Rhee; John D McKinney
Journal:  J Immunol       Date:  2011-08-22       Impact factor: 5.422

6.  Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease.

Authors:  E Gonzalez-Rey; A Fernandez-Martin; A Chorny; M Delgado
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

Review 7.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

8.  Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.

Authors:  Martin Weygandt; Lil Meyer-Arndt; Janina Ruth Behrens; Katharina Wakonig; Judith Bellmann-Strobl; Kerstin Ritter; Michael Scheel; Alexander U Brandt; Christian Labadie; Stefan Hetzer; Stefan M Gold; Friedemann Paul; John-Dylan Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

9.  Neural pathways in allergic inflammation.

Authors:  L Mirotti; J Castro; F A Costa-Pinto; M Russo
Journal:  J Allergy (Cairo)       Date:  2011-02-09

10.  Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year.

Authors:  Lawrence Steinman
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.